Nine Masts Capital’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Nine Masts Capital’s Portfolio MR Stock Details MR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-1,327,187	Closed	-$36M	–	108
2015 Q4	$36M	Buy	1,327,187 +1,250,187	+1,624%	+$32.2M	7.38%	3
2015 Q3	$1.68M	Buy	77,000 +54,100	+236%	+$1.38M	0.43%	34
2015 Q2	$653K	Buy	+22,900	New	+$667K	0.21%	43

Other funds holding MR

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Nine Masts Capital's MR Position: Q1 2016 in Review

Nine Masts Capital sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 1,327,187 shares — an estimated $36M sold.

Nine Masts Capital first reported a position in MR in Q2 2015 and held it in 3 quarters. The position peaked at $36M in Q4 2015. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

Nine Masts Capital reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
Nine Masts Capital sold 1,327,187 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $36M.
Nine Masts Capital first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2015 and held it in 3 quarters.
Nine Masts Capital's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $36M in Q4 2015.
2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on Nine Masts Capital's 13F filing for Q1 2016, filed 16 May 2016.